https://biotechmorning.com/news/gilead-tubulis-5-billion-adc-acquisition-2 Biotech Morning en 2026-06-26T14:26:31.726Z Gilead Just Dropped $5 Billion on a German Startup You've Never Heard Of https://biotechmorning.com/news/pharma-pricing-deals-trump-tariffs Biotech Morning en 2026-06-26T14:25:40.071Z Big Pharma Just Cut a Deal With the White House. Here's What They Gave Up. https://biotechmorning.com/news/daraxonrasib-doubles-survival-pancreatic-cancer Biotech Morning en 2026-06-26T14:24:42.972Z The Drug That Made an ASCO Crowd Stand and Cheer for 42 Seconds https://biotechmorning.com/news/crispr-base-editing-human-embryos-precision-ethics Biotech Morning en 2026-06-26T14:23:48.643Z Scientists Can Now Edit Human Embryos With Surgical Precision. That's the Problem. https://biotechmorning.com/news/gilead-kymera-molecular-glue-degrader-deal Biotech Morning en 2026-06-26T14:22:59.296Z Gilead Just Paid $45M for a Drug That Doesn't Exist Yet https://biotechmorning.com/news/novartis-antares-undruggable-cancer-deal Biotech Morning en 2026-06-26T14:21:59.918Z Novartis Just Bet $1.9 Billion on a Company That Doesn't Exist Yet https://biotechmorning.com/news/moderna-in-vivo-car-t-autoimmune Biotech Morning en 2026-06-26T14:21:04.031Z Moderna Wants to Build a CAR-T Factory Inside Your Body https://biotechmorning.com/news/ucb-neurona-therapeutics-cell-therapy-epilepsy-deal Biotech Morning en 2026-06-26T14:20:09.049Z UCB Just Bet $1.15 Billion That Brain Cells Can Stop Seizures https://biotechmorning.com/news/ms-drug-does-what-no-drug-has-done-before Biotech Morning en 2026-06-26T14:19:13.108Z The MS Drug That Does What No Drug Has Done Before https://biotechmorning.com/news/ai-designed-lung-drug-rentosertib-ipf-phase-2a Biotech Morning en 2026-06-25T14:28:42.428Z The Robot That Designed a Lung Drug (and It Actually Worked) https://biotechmorning.com/news/fda-ngs-genome-editing-off-target-guidance Biotech Morning en 2026-06-25T14:27:52.585Z The FDA Just Told CRISPR Companies Exactly How to Prove Their Edits Are Safe https://biotechmorning.com/news/one-shot-to-silence-disease-forever-intellia-crispr Biotech Morning en 2026-06-25T14:26:59.430Z One Shot to Silence a Disease Forever https://biotechmorning.com/news/merck-kgaa-bio-techne-acquisition-11-billion Biotech Morning en 2026-06-25T14:26:01.236Z Merck KGaA Just Dropped $11 Billion on a Company Most People Never Heard Of https://biotechmorning.com/news/ibrance-hER2-positive-breast-cancer-maintenance-approval Biotech Morning en 2026-06-25T14:25:05.164Z Ibrance Just Crossed a Line Nobody Thought It Could https://biotechmorning.com/news/nipocalimab-waiha-first-approved-treatment Biotech Morning en 2026-06-25T14:24:13.981Z The Blood Disease Nobody Could Treat Just Got Its First Real Shot https://biotechmorning.com/news/biosecure-act-china-biotech-expansion Biotech Morning en 2026-06-25T14:23:25.976Z The $6 Billion Wall That China's Biotech Giants Keep Walking Through https://biotechmorning.com/news/alzpath-abbott-alzheimer-blood-test-deal Biotech Morning en 2026-06-25T14:22:29.974Z The $17 Blood Test That Could Rewrite Alzheimer's Diagnosis https://biotechmorning.com/news/pfizer-berobenatide-monthly-glp1-phase-2b Biotech Morning en 2026-06-25T14:21:42.476Z Pfizer Just Made the GLP-1 Shot a Once-a-Month Thing https://biotechmorning.com/news/trodelvy-first-line-tnbc-fda-approval Biotech Morning en 2026-06-25T14:20:43.430Z Trodelvy Just Jumped the Line in Breast Cancer Treatment https://biotechmorning.com/news/pig-kidney-271-days-fda-expansion Biotech Morning en 2026-06-25T14:19:53.694Z A Pig Kidney Kept a Man Alive for 271 Days. Now the FDA Wants More.